You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Self-collected Samples for Testing of Oncogenic Human Papillomavirus

ID: HPVTest Apr 2006
Type of Content: Guidelines & Advice, Clinical
Document Status: Education and Information
HPV Self-collection Guidelines Panel

Patient Population

Women in Ontario for whom cervical cancer screening is recommended with an emphasis on those who are never or seldom (> three years) screened by clinicians.

Research Question(s)

What is the role of self-sampling for human papillomavirus (HPV) testing as an alternative to cervical cancer screening by clinicians (i.e., Pap test)? Specifically, for HPV DNA testing:

  1. What are the potential benefits and harms of self-sampling?
  2. Is it feasible for women to successfully perform self-sampling?
  3. With self-sampling, are samples obtained by women adequate for analysis?
  4. What is the accuracy of self-sampling?
  5. Is self-sampling acceptable to women?
  6. Is self-sampling appealing to women?
  7. Do specific characteristics of women influence preferences regarding self-sampling?
  8. Is self-sampling appropriate for women who are never or seldom screened by clinicians?
pdf download Full Report (PDF) (895.44 KB)